{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:54:56Z","timestamp":1792007696789,"version":"4.4.0"},"reference-count":130,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Carnitine is an amino acid-derived substance that coordinates a wide range of biological processes. Such functions include transport of long-chain fatty acids from the cytoplasm to the mitochondrial matrix, regulation of acetyl-CoA\/CoA, control of inter-organellar acyl traffic, and protection against oxidative stress. Recent studies have found that carnitine plays an important role in several diseases, including non-alcoholic fatty liver disease (NAFLD). However, its effect is still controversial, and its mechanism is not clear. Herein, this review provides current knowledge on the biological functions of carnitine, the \u201cmultiple hit\u201d impact of carnitine on the NAFLD progression, and the downstream mechanisms. Based on the \u201cmultiple hit\u201d hypothesis, carnitine inhibits \u03b2-oxidation, improves mitochondrial dysfunction, and reduces insulin resistance to ameliorate NAFLD. L-carnitine may have therapeutic role in liver diseases including non-alcoholic steatohepatitis, cirrhosis, hepatocellular carcinoma, alcoholic fatty liver disease, and viral hepatitis. We also discuss the prospects of L-carnitine supplementation as a therapeutic strategy in NAFLD and related diseases, and the factors limiting its widespread use.<\/jats:p>","DOI":"10.3389\/fmed.2021.689042","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T05:55:46Z","timestamp":1628488546000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":65,"title":["Role of Carnitine in Non-alcoholic Fatty Liver Disease and Other Related Diseases: An Update"],"prefix":"10.3389","volume":"8","author":[{"given":"Na","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.3390\/molecules24183251","article-title":"Carnitine inborn errors of metabolism","volume":"24","author":"Almannai","year":"2019","journal-title":"Molecules"},{"key":"B2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.gene.2013.10.017","article-title":"L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders","volume":"533","author":"Ribas","year":"2014","journal-title":"Gene"},{"key":"B3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1475-2891-13-79","article-title":"Effects of L-carnitine supplementation on oxidative stress and antioxidant enzymes activities in patients with coronary artery disease: a randomized, placebo-controlled trial","volume":"13","author":"Lee","year":"2014","journal-title":"Nutr J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jpeds.2006.09.042","article-title":"Histopathologic abnormalities of the lymphoreticular tissues in organic cation transporter 2 deficiency: evidence for impaired B cell maturation","volume":"150","author":"Koml\u00f3si","year":"2007","journal-title":"J Pediatr"},{"key":"B5","first-page":"74","article-title":"Analyzing mitochondrial dysfunction, oxidative stress, and apoptosis: potential role of L-carnitine","volume":"13","author":"Modanloo","year":"2019","journal-title":"Iran J Kidney Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41387-018-0017-1","article-title":"Role of carnitine and its derivatives in the development and management of type 2 diabetes","volume":"8","author":"Bene","year":"2018","journal-title":"Nutr Diabetes"},{"key":"B7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.17219\/acem\/61609","article-title":"L-carnitine treatment of insulin resistance: a systematic review and meta-analysis","volume":"26","author":"Xu","year":"2017","journal-title":"Adv Clin Exp Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/09513590.2017.1290071","article-title":"Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial","volume":"33","author":"Jamilian","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1080\/07315724.2015.1068139","article-title":"Effects of l-Carnitine supplementation on serum inflammatory factors and matrix metalloproteinase enzymes in females with knee osteoarthritis: a randomized, double-blind, placebo-controlled pilot study","volume":"35","author":"Malek Mahdavi","year":"2016","journal-title":"J Am Coll Nutr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/iub.1646","article-title":"Significance of l-carnitine for human health","volume":"69","author":"Adeva-Andany","year":"2017","journal-title":"IUBMB Life"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.4155\/bio.15.155","article-title":"Bioanalysis and enantioseparation of dl-carnitine in human plasma by the derivatization approach","volume":"7","author":"Vashistha","year":"2015","journal-title":"Bioanalysis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1017\/S000711451900148X","article-title":"Functional differences between l- and d-carnitine in metabolic regulation evaluated using a low-carnitine Nile tilapia model","volume":"122","author":"Li","year":"2019","journal-title":"Br J Nutr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4161\/oxim.3.4.12859","article-title":"Carnitine deficiency and oxidative stress provoke cardiotoxicity in an ifosfamide-induced Fanconi Syndrome rat model","volume":"3","author":"Sayed-Ahmed","year":"2010","journal-title":"Oxid Med Cell Longev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tox.2008.09.010","article-title":"Carnitine deficiency aggravates carboplatin nephropathy through deterioration of energy status, oxidant\/anti-oxidant balance, and inflammatory endocoids","volume":"254","author":"Arafa","year":"2008","journal-title":"Toxicology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/foods9040481","article-title":"An untargeted metabolomics investigation of Jiulong Yak (Bos grunniens) meat by H-NMR","volume":"9","author":"Zhu","year":"2020","journal-title":"Foods"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1096\/fasebj.6.15.1464372","article-title":"Carnitine function and requirements during the life cycle","volume":"6","author":"Rebouche","year":"1992","journal-title":"FASEB J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1196\/annals.1320.004","article-title":"Carnitine deficiency disorders in children","volume":"1033","author":"Stanley","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1006\/abbi.1996.0203","article-title":"Characterization of the human plasmalemmal carnitine transporter in cultured skin fibroblasts","volume":"329","author":"Tein","year":"1996","journal-title":"Arch Biochem Biophys"},{"key":"B20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.mam.2004.06.006","article-title":"Carnitine: a nutritional, biosynthetic, and functional perspective","volume":"25","author":"Steiber","year":"2004","journal-title":"Mol Aspects Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1152\/physrev.1983.63.4.1420","article-title":"Carnitine\u2013metabolism and functions","volume":"63","author":"Bremer","year":"1983","journal-title":"Physiol Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/bj3610417","article-title":"Carnitine biosynthesis in mammals","volume":"361","author":"Vaz","year":"2002","journal-title":"Biochem J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/iub.323","article-title":"Enzymology of the carnitine biosynthesis pathway","volume":"62","author":"Strijbis","year":"2010","journal-title":"IUBMB Life"},{"key":"B24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1196\/annals.1320.003","article-title":"Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism","volume":"1033","author":"Rebouche","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/db12-0466","article-title":"Acylcarnitines: reflecting or inflicting insulin resistance?","volume":"62","author":"Schooneman","year":"2013","journal-title":"Diabetes"},{"key":"B26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1006\/mgme.2001.3207","article-title":"Carnitine transport by organic cation transporters and systemic carnitine deficiency","volume":"73","author":"Lahjouji","year":"2001","journal-title":"Mol Genet Metab"},{"key":"B27","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1017\/S000711450775691X","article-title":"Dietary oxidised fat up regulates the expression of organic cation transporters in liver and small intestine and alters carnitine concentrations in liver, muscle and plasma of rats","volume":"98","author":"Koch","year":"2007","journal-title":"Br J Nutr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1080\/14728222.2018.1502273","article-title":"Recent advances in drug delivery via the organic cation\/carnitine transporter 2 (OCTN2\/SLC22A5)","volume":"22","author":"Kou","year":"2018","journal-title":"Expert Opin Ther Targets"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1388-1981(00)00044-5","article-title":"Fatty acid import into mitochondria","volume":"1486","author":"Kerner","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.3748\/wjg.v21.i12.3492","article-title":"Long-chain acyl-CoA synthetase in fatty acid metabolism involved in liver and other diseases: an update","volume":"21","author":"Yan","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.mam.2011.10.008","article-title":"The mitochondrial carnitine\/acylcarnitine carrier: function, structure and physiopathology","volume":"32","author":"Indiveri","year":"2011","journal-title":"Mol Aspects Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1432-1033.1997.00001.x","article-title":"The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis","volume":"244","author":"McGarry","year":"1997","journal-title":"Eur J Biochem"},{"key":"B33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/GIM.0b013e3181614289","article-title":"Acylcarnitine profile analysis","volume":"10","author":"Rinaldo","year":"2008","journal-title":"Genet Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.3390\/nu12082178","article-title":"The importance of the fatty acid transporter L-carnitine in non-alcoholic fatty liver disease (NAFLD)","volume":"12","author":"Savic","year":"2020","journal-title":"Nutrients"},{"key":"B35","first-page":"246","article-title":"Carnitine metabolism and human carnitine deficiency","volume":"9","author":"Tanphaichitr","year":"1993","journal-title":"Nutrition"},{"key":"B36","first-page":"35","article-title":"Mitochondrial dysfunction and chronic disease: treatment with natural supplements","volume":"13","author":"Nicolson","year":"2014","journal-title":"Integr Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41371-019-0248-1","article-title":"Effects of L-carnitine supplementation on blood pressure: a systematic review and meta-analysis of randomized controlled trials","volume":"33","author":"Askarpour","year":"2019","journal-title":"J Hum Hypertens"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/ggi.14060","article-title":"l-Carnitine supplementation in heart failure patients with preserved ejection fraction; a pilot study","volume":"20","author":"Kinugasa","year":"2020","journal-title":"Geriatr Gerontol Int"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1080\/13813455.2020.1797102","article-title":"L-Carnitine supplementation reduces biomarkers of inflammatory and oxidative stress in patients with coronary artery disease: a randomised controlled trial","author":"Nachvak","year":"2020","journal-title":"Arch Physiol Biochem"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3390\/nu12071915","article-title":"Usefulness of carnitine supplementation for the complications of liver cirrhosis","volume":"12","author":"Hanai","year":"2020","journal-title":"Nutrients"},{"key":"B41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/07315724.2019.1661804","article-title":"The effect of L-carnitine supplementation on exercise-induced muscle damage: a systematic review and meta-analysis of randomized clinical trials","volume":"39","author":"Yarizadh","year":"2020","journal-title":"J Am Coll Nutr"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.numecd.2019.07.012","article-title":"Efficacy of l-carnitine supplementation for management of blood lipids: a systematic review and dose-response meta-analysis of randomized controlled trials","volume":"29","author":"Askarpour","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1177\/0333102418821661","article-title":"The effects of concurrent Coenzyme Q10, L-carnitine supplementation in migraine prophylaxis: a randomized, placebo-controlled, double-blind trial","volume":"39","author":"Hajihashemi","year":"2019","journal-title":"Cephalalgia"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.3390\/nu12071987","article-title":"Preventive role of L-carnitine and balanced diet in Alzheimer's disease","volume":"12","author":"Kepka","year":"2020","journal-title":"Nutrients"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/hep.31533","article-title":"Tackling NAFLD: three targeted populations","volume":"73","author":"Wegermann","year":"2020","journal-title":"Hepatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/MPG.0000000000002875","article-title":"Lipidomics in nonalcoholic fatty liver disease: exploring serum lipids as biomarkers for pediatric nonalcoholic fatty liver disease","volume":"71","author":"Draijer","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"B48","doi-asserted-by":"publisher","first-page":"831670","DOI":"10.1155\/2009\/831670","article-title":"Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy","volume":"2009","author":"Tsochatzis","year":"2009","journal-title":"Mediators Inflamm"},{"key":"B49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3892\/etm.2020.9154","article-title":"Abnormal metabolic processes involved in the pathogenesis of non-alcoholic fatty liver disease (Review)","volume":"20","author":"Shao","year":"2020","journal-title":"Exp Ther Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/MPG.0b013e31822578db","article-title":"Mechanisms of lipotoxicity in NAFLD and clinical implications","volume":"53","author":"Ibrahim","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B51","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11154-018-9448-1","article-title":"Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle","volume":"19","author":"Knottnerus","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e1900942","DOI":"10.1002\/mnfr.201900942","article-title":"Mitochondrial dysfunction is a key pathway that links saturated fat intake to the development and progression of NAFLD","volume":"65","author":"Meex","year":"2020","journal-title":"Mol Nutr Food Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/j.1478-3231.2011.02602.x","article-title":"Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction","volume":"31","author":"Jun","year":"2011","journal-title":"Liver Int"},{"key":"B54","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/hep.1840380426","article-title":"Defective hepatic mitochondrial respiratory chain in patients with non-alcoholic steatohepatitis","volume":"38","author":"Perez-Carreras","year":"2003","journal-title":"Hepatology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00394-011-0284-2","article-title":"Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency","volume":"51","author":"Ringseis","year":"2012","journal-title":"Eur J Nutr"},{"key":"B56","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.metabol.2017.09.005","article-title":"Carnitine induces autophagy and restores high-fat diet-induced mitochondrial dysfunction","volume":"78","author":"Choi","year":"2018","journal-title":"Metabolism"},{"key":"B57","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1210\/er.2008-0047","article-title":"Insulin receptor isoforms and insulin receptor\/insulin-like growth factor receptor hybrids in physiology and disease","volume":"30","author":"Belfiore","year":"2009","journal-title":"Endocr Rev"},{"key":"B58","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/biom11020217","article-title":"Insulin-like growth factor-1 (IGF-1) and its monitoring in medical diagnostic and in sports","volume":"11","author":"Bailes","year":"2021","journal-title":"Biomolecules"},{"key":"B59","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.tem.2015.11.009","article-title":"Endothelial IGF-1 receptor signalling in diabetes and insulin resistance","volume":"27","author":"Cubbon","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"B60","doi-asserted-by":"publisher","first-page":"26087","DOI":"10.3390\/ijms161125942","article-title":"The role of oxidative stress and antioxidants in liver diseases","volume":"16","author":"Li","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B61","doi-asserted-by":"publisher","first-page":"9037051","DOI":"10.1155\/2016\/9037051","article-title":"Role of oxidative stress in liver health and disease","volume":"2016","author":"Muriel","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1001\/jama.282.17.1659","article-title":"Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study","volume":"282","author":"Cortez-Pinto","year":"1999","journal-title":"JAMA"},{"key":"B63","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1365-2362.2008.01936.x","article-title":"Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model","volume":"38","author":"Serviddio","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"B64","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/pmj.79.932.307","article-title":"Evaluation of abnormal liver function tests","volume":"79","author":"Limdi","year":"2003","journal-title":"Postgrad Med J"},{"key":"B65","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1046\/j.1442-200X.2001.01423.x","article-title":"Plasma and liver carnitine status of children with chronic liver disease and cirrhosis","volume":"43","author":"Selimoglu","year":"2001","journal-title":"Pediatr Int"},{"key":"B66","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1172\/JCI108824","article-title":"Deficiency of carnitine in cachectic cirrhotic patients","volume":"60","author":"Rudman","year":"1977","journal-title":"J Clin Invest"},{"key":"B67","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/hep.23623","article-title":"A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease","volume":"52","author":"Musso","year":"2010","journal-title":"Hepatology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/jpen.1720","article-title":"l-Carnitine improves postoperative liver function in hepatectomized patients","volume":"44","author":"Okabayashi","year":"2020","journal-title":"J Parenter Enteral Nutr"},{"key":"B69","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1196\/annals.1320.012","article-title":"Carnitines and its congeners: a metabolic pathway to the regulation of immune response and inflammation","volume":"1033","author":"Famularo","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"21388","DOI":"10.1074\/jbc.272.34.21388","article-title":"Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis","volume":"272","author":"Quillet-Mary","year":"1997","journal-title":"J Biol Chem"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1056\/NEJM198012113032403","article-title":"Systemic carnitine deficiency\u2013a treatable inherited lipid-storage disease presenting as Reye's syndrome","volume":"303","author":"Chapoy","year":"1980","journal-title":"N Engl J Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbabio.2010.10.022","article-title":"Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells","volume":"1807","author":"Pike","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B73","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1743-7075-7-30","article-title":"Role of carnitine in disease","volume":"7","author":"Flanagan","year":"2010","journal-title":"Nutr Metab"},{"key":"B74","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/15563650902752376","article-title":"Carnitine in the treatment of valproic acid-induced toxicity","volume":"47","author":"Lheureux","year":"2009","journal-title":"Clin Toxicol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4103\/0028-3886.173650","article-title":"Primary carnitine deficiency as a cause of metabolic leukoencephalopathy: report of one case","volume":"64","author":"Mahale","year":"2016","journal-title":"Neurol India"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000448320","article-title":"Historical perspective on clinical trials of carnitine in children and adults","volume":"68","author":"Buist","year":"2016","journal-title":"Ann Nutr Metab"},{"key":"B77","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1093\/ajcn\/39.5.738","article-title":"Ameliorating effects of carnitine and its precursors on alcohol-induced fatty liver","volume":"39","author":"Sachan","year":"1984","journal-title":"Am J Clin Nutr"},{"key":"B78","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/jn\/91.3_Suppl.331","article-title":"Fatty liver in the rat after prolonged intake of ethanol with a nutritionally adequate new liquid diet","volume":"91","author":"DeCarli","year":"1967","journal-title":"J Nutr"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/0024-3205(73)90380-9","article-title":"Studies on the ethanol-induced decrease of fatty acid oxidation in rat and human liver slices","volume":"13","author":"Blomstrand","year":"1973","journal-title":"Life Sci"},{"key":"B80","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3350\/cmh.2013.19.2.165","article-title":"Efficacy and safety of entecavir plus carnitine complex (GODEX\u00ae) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study","volume":"19","author":"Jun","year":"2013","journal-title":"Clin Mol Hepatol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.3346\/jkms.2020.35.e104","article-title":"Influence of besifovir dipivoxil maleate combined with L-carnitine on hepatic steatosis in patients with chronic hepatitis B","volume":"35","author":"Jung","year":"2020","journal-title":"J Korean Med Sci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3746\/pnf.2020.25.2.124","article-title":"Effect of L-carnitine supplementation on lipid profiles of patients with liver disease: a systematic review and meta-analysis","volume":"25","author":"Abbasnezhad","year":"2020","journal-title":"Prev Nutr Food Sci"},{"key":"B83","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/jmv.24692","article-title":"Anti-adipogenic and antiviral effects of l-carnitine on hepatitis C virus infection","volume":"89","author":"Tsukuda","year":"2017","journal-title":"J Med Virol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00018-003-3216-3","article-title":"Peroxisome proliferator-activated receptor alpha target genes","volume":"61","author":"Mandard","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"B85","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/2050-6511-15-37","article-title":"Pharmacological doses of niacin stimulate the expression of genes involved in carnitine uptake and biosynthesis and improve the carnitine status of obese Zucker rats","volume":"15","author":"Couturier","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"868317","DOI":"10.1155\/2012\/868317","article-title":"Regulation of genes involved in carnitine homeostasis by PPAR\u03b1 across different species (rat, mouse, pig, cattle, chicken, and human)","volume":"2012","author":"Ringseis","year":"2012","journal-title":"PPAR Res"},{"key":"B87","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.dld.2019.09.002","article-title":"L-carnitine supplementation attenuates NAFLD progression and cardiac dysfunction in a mouse model fed with methionine and choline-deficient diet","volume":"52","author":"Mollica","year":"2020","journal-title":"Dig Liver Dis"},{"key":"B88","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.3748\/wjg.v20.i28.9217","article-title":"Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?","volume":"20","author":"Scalera","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e9495","DOI":"10.15252\/msb.209495","article-title":"The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non-alcoholic fatty liver disease","volume":"16","author":"Zhang","year":"2020","journal-title":"Mol Syst Biol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40618-019-01134-2","article-title":"L-Carnitine counteracts in vitro fructose-induced hepatic steatosis through targeting oxidative stress markers","volume":"43","author":"Montesano","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"B91","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.3390\/ijms20184359","article-title":"Combined treatment with L-carnitine and nicotinamide riboside improves hepatic metabolism and attenuates obesity and liver steatosis","volume":"20","author":"Salic","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e103607","DOI":"10.5812\/hepatmon.103607","article-title":"Composite BMI and waist-to-height ratio index for risk assessment of non-alcoholic fatty liver disease in adult populations","volume":"20","author":"Li","year":"2020","journal-title":"Hepat Mon"},{"key":"B93","doi-asserted-by":"publisher","first-page":"101049","DOI":"10.1016\/j.molmet.2020.101049","article-title":"Non-alcoholic fatty liver disease and steatohepatitis: state of the art on effective therapeutics based on the gold standard method for diagnosis","volume":"50","author":"Mahjoubin-Tehran","year":"2021","journal-title":"Mol Metab"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.17554\/j.issn.2224-3992.2016.05.662","article-title":"Evaluation of l-carnitine efficacy in the treatment of non-alcoholic fatty liver disease among diabetic patients: a randomized double blind pilot study","volume":"5","author":"Alavinejad","year":"2016","journal-title":"J Gastroenterol Hepatol Res"},{"key":"B95","doi-asserted-by":"publisher","first-page":"102273","DOI":"10.1016\/j.ctim.2019.102273","article-title":"The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"48","author":"Abolfathi","year":"2020","journal-title":"Comp Ther Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s00394-019-02068-4","article-title":"Does L-carnitine supplementation affect serum levels of enzymes mainly produced by liver? A systematic review and meta-analysis of randomized controlled clinical trials","volume":"59","author":"Pirmadah","year":"2020","journal-title":"Eur J Nutr"},{"key":"B97","doi-asserted-by":"publisher","first-page":"575","DOI":"10.6026\/97320630010575","article-title":"Data from a randomized and controlled trial of L-carnitine prescription for the treatment for non- alcoholic fatty liver disease","volume":"10","author":"Somi","year":"2014","journal-title":"Bioinformation"},{"key":"B98","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4166\/kjg.2010.55.6.384","article-title":"Effects of carnitine on peripheral blood mitochondrial DNA copy number and liver function in non-alcoholic fatty liver disease","volume":"55","author":"Lim","year":"2010","journal-title":"Korean J Gastroenterol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1038\/s41598-017-02924-5","article-title":"Evaluation of the effects of L-carnitine on medaka (Oryzias latipes) fatty liver","volume":"7","author":"Fujisawa","year":"2017","journal-title":"Sci Rep"},{"key":"B100","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.nutres.2013.08.001","article-title":"Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease","volume":"33","author":"Kathirvel","year":"2013","journal-title":"Nutr Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2337\/dc14-2852","article-title":"Improvement of nonalcoholic fatty liver disease with carnitine-orotate complex in type 2 diabetes (CORONA): a randomized controlled trial","volume":"38","author":"Bae","year":"2015","journal-title":"Diabetes Care"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/jgh.12536","article-title":"Effect of carnitine-orotate complex on glucose metabolism and fatty liver: a double-blind, placebo-controlled study","volume":"29","author":"Hong","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.arcmed.2016.11.010","article-title":"Serum chemerin in obese children and adolescents before and after L-carnitine therapy: relation to nonalcoholic fatty liver disease and other features of metabolic syndrome","volume":"47","author":"Hamza","year":"2016","journal-title":"Arch Med Res"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/ajg.2009.719","article-title":"L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis\u2013a randomized and controlled clinical trial","volume":"105","author":"Malaguarnera","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e100627","DOI":"10.1371\/journal.pone.0100627","article-title":"L-carnitine prevents progression of non-alcoholic steatohepatitis in a mouse model with upregulation of mitochondrial pathway","volume":"9","author":"Ishikawa","year":"2014","journal-title":"PLoS ONE"},{"key":"B106","doi-asserted-by":"publisher","first-page":"608216","DOI":"10.1155\/2015\/608216","article-title":"Effects of oral L-carnitine on liver functions after transarterial chemoembolization in intermediate-stage HCC patients","volume":"2015","author":"Hassan","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B107","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000073347","article-title":"L-Carnitine in the treatment of mild or moderate hepatic encephalopathy","volume":"21","author":"Malaguarnera","year":"2003","journal-title":"Dig Dis"},{"key":"B108","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11011-011-9260-z","article-title":"Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial","volume":"26","author":"Malaguarnera","year":"2011","journal-title":"Metab Brain Dis"},{"key":"B109","doi-asserted-by":"publisher","first-page":"7197","DOI":"10.3748\/wjg.v11.i45.7197","article-title":"Effects of L-carnitine in patients with hepatic encephalopathy","volume":"11","author":"Malaguarnera","year":"2005","journal-title":"World J Gastroenterol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1007\/s10620-006-9187-0","article-title":"Effects of L-acetylcarnitine on cirrhotic patients with hepatic coma: randomized double-blind, placebo-controlled trial","volume":"51","author":"Malaguarnera","year":"2006","journal-title":"Dig Dis Sci"},{"key":"B111","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1007\/s10620-008-0238-6","article-title":"Acetyl-L-carnitine treatment in minimal hepatic encephalopathy","volume":"53","author":"Malaguarnera","year":"2008","journal-title":"Dig Dis Sci"},{"key":"B112","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/0735-1097(95)80010-E","article-title":"Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-carnitine ecocardiografia digitalizzata infarto miocardico (CEDIM) trial","volume":"26","author":"Iliceto","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1054\/plef.2002.0378","article-title":"Efficacy of carnitine in the treatment of children with attention-deficit hyperactivity disorder","volume":"67","author":"Van Oudheusden","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B114","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/088307389901400306","article-title":"Rett syndrome: randomized controlled trial of L-carnitine","volume":"14","author":"Ellaway","year":"1999","journal-title":"J Child Neurol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1210\/jcem.86.8.7747","article-title":"Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial","volume":"86","author":"Benvenga","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B116","first-page":"38","article-title":"Does left ventricular function improve with L-carnitine after acute myocardial infarction?","volume":"45","author":"Iyer","year":"1999","journal-title":"J Postgrad Med"},{"key":"B117","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1023\/A:1007883822625","article-title":"Prolonged oral L-carnitine substitution increases bicycle ergometer performance in patients with severe, ischemically induced cardiac insufficiency","volume":"13","author":"L\u00f6ster","year":"1999","journal-title":"Cardiovasc Drugs Ther"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.fertnstert.2003.10.034","article-title":"A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia","volume":"81","author":"Lenzi","year":"2004","journal-title":"Fertil Steril"},{"key":"B119","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1017\/S1041610298005304","article-title":"Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease: a reanalysis of a double-blind, placebo-controlled study using the trilinear approach","volume":"10","author":"Brooks","year":"1998","journal-title":"Int Psychogeriatr"},{"key":"B120","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/BF02291384","article-title":"Long-term effect of acetyl-L-carnitine on myocardial 123I-MIBG uptake in patients with diabetes","volume":"10","author":"Turpeinen","year":"2000","journal-title":"Clin Auton Res"},{"key":"B121","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/(SICI)1096-8628(19991203)87:4<366::AID-AJMG18>3.0.CO;2-F","article-title":"Double-blind, placebo-controlled study of L-acetylcarnitine for the treatment of hyperactive behavior in fragile X syndrome","volume":"87","author":"Torrioli","year":"1999","journal-title":"Am J Med Genet"},{"key":"B122","first-page":"29","article-title":"Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial","volume":"25","author":"Dal Lago","year":"1999","journal-title":"Drugs Exp Clin Res"},{"key":"B123","first-page":"63","article-title":"Effect of l-carnitine and raspberry ketones on metabolic parameters in iraqi obese females, a comparative study","volume":"31","author":"Mosah","year":"2015","journal-title":"Int J Pharm Sci Rev Res"},{"key":"B124","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/ajmg.c.30087","article-title":"Disorders of carnitine transport and the carnitine cycle","author":"Longo","year":"2006","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"B125","doi-asserted-by":"publisher","first-page":"618S","DOI":"10.1093\/ajcn\/72.2.618S","article-title":"Supplemental carnitine and exercise","volume":"72","author":"Brass","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"B126","doi-asserted-by":"publisher","first-page":"104554","DOI":"10.1016\/j.phrs.2019.104554","article-title":"Beneficial effects of l-carnitine supplementation for weight management in overweight and obese adults: an updated systematic review and dose-response meta-analysis of randomized controlled trials","volume":"151","author":"Askarpour","year":"2020","journal-title":"Pharmacol Res"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1159\/000491807","article-title":"The unexpected effects of L-carnitine supplementation on lipid metabolism in hemodialysis patients","volume":"43","author":"Katalinic","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2013.03.004","article-title":"A systematic review to evaluate the effectiveness of carnitine supplementation in improving walking performance among individuals with intermittent claudication","volume":"229","author":"Delaney","year":"2013","journal-title":"Atherosclerosis"},{"key":"B129","doi-asserted-by":"publisher","first-page":"e0239506","DOI":"10.1371\/journal.pone.0239506","article-title":"L-carnitine infusion does not alleviate lipid-induced insulin resistance and metabolic inflexibility","volume":"15","author":"Bruls","year":"2020","journal-title":"PLoS ONE"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1136\/gutjnl-2017-315193","article-title":"CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity","volume":"67","author":"Fujiwara","year":"2018","journal-title":"Gut"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.689042\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T05:56:06Z","timestamp":1628488566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.689042\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":130,"alternative-id":["10.3389\/fmed.2021.689042"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.689042","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"article-number":"689042"}}